£795.00

The 2021-2026 World Outlook for Lung Cancer Therapeutics

Price data last checked 149 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

It has never been this cheap. We have no record of a lower price.

£795 today · cheaper than every other day in the last 24 months

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 582 days • 582 data points (No recent data available)

Historical
Generating forecast...
£795.00 £755.25 £771.15 £787.05 £802.95 £818.85 £834.75 10 June 2024 02 November 2024 27 March 2025 19 August 2025 12 January 2026

Price Distribution

Price distribution over 582 days • 1 price levels

Days at Price
582 days 0 146 291 437 582 £795 Days at Price

Price Analysis

Most common price: £795 (582 days, 100.0%)

Price range: £795 - £795

Price levels: 1 different prices over 582 days

Product Specifications

Format
paperback
Domain
Amazon UK
Release Date
13 February 2020
Listed Since
17 December 2019

Similar Products You Might Like

The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics
99% match

The 2025-2030 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£790.00 14 Apr 2026
The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics
99% match

The 2016-2021 World Outlook for Non-Small Cell Lung Cancer Therapeutics

£995.00 11 Jan 2026
The 2025-2030 World Outlook for Non-Small Cell Lung Cancers
99% match

The 2025-2030 World Outlook for Non-Small Cell Lung Cancers

£790.00 22 Jan 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India
99% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in India

£515.00 09 Apr 2026
The 2023-2028 Outlook for Lung Cancer Screening Software in India
98% match

The 2023-2028 Outlook for Lung Cancer Screening Software in India

£515.00 23 Jan 2026
The 2023-2028 Outlook for Lung Cancer Screening Software in the United States
98% match

The 2023-2028 Outlook for Lung Cancer Screening Software in the United States

£520.00 13 Jan 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in China

£495.00 14 Apr 2026
The 2023 Report on Non-Small Cell Lung Cancer Therapeutics: World Market Segmentation by City
98% match

The 2023 Report on Non-Small Cell Lung Cancer Therapeutics: World Market Segmentation by City

£795.00 15 Apr 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in India

£515.00 14 Apr 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in Japan

£495.00 18 Mar 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£520.00 10 Apr 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in the United States

£520.00 15 Apr 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in China
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in China

£495.00 15 Apr 2026
The 2023-2028 Outlook for Non-Small Cell Lung Cancers in Japan
98% match

The 2023-2028 Outlook for Non-Small Cell Lung Cancers in Japan

£495.00 18 Mar 2026
The 2011-2016 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa, Europe & the Middle East
98% match

The 2011-2016 Outlook for Non-Small Cell Lung Cancer Therapeutics in Africa, Europe & the Middle East

£325.00 13 Dec 2025
The 2023-2028 World Outlook for Lung Cancer Screening Software
98% match

The 2023-2028 World Outlook for Lung Cancer Screening Software

Out of Stock 13 Jan 2026
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe
98% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Europe

£325.00 31 Mar 2026
The 2023-2028 World Outlook for Non-Small Cell Lung Cancers
98% match

The 2023-2028 World Outlook for Non-Small Cell Lung Cancers

Out of Stock 23 Jan 2026
The 2021-2026 World Outlook for Silent Cancer Therapeutics
98% match

The 2021-2026 World Outlook for Silent Cancer Therapeutics

£795.00 08 Jan 2026
The 2023-2028 Outlook for Lung Cancer Screening Software in Japan
98% match

The 2023-2028 Outlook for Lung Cancer Screening Software in Japan

£495.00 13 Dec 2025
The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Asia
98% match

The 2013-2018 Outlook for Non-Small Cell Lung Cancer Therapeutics in Asia

£325.00 31 Jan 2026
The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States
98% match

The 2016-2021 Outlook for Non-Small Cell Lung Cancer Therapeutics in the United States

£595.00 12 Jan 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in India
98% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in India

£515.00 22 Jan 2026
The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States
97% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in the United States

£520.00 22 Jan 2026